Skip to main content
. 2022 Apr 18;12(4):e052329. doi: 10.1136/bmjopen-2021-052329

Table 1.

Inclusion and exclusion criteria

Inclusion criteria Exclusion criteria
1. ≥18 years of age 1. Atypical parkinsonian syndromes
2. ≥21 on the Montreal Cognitive Assessment53 2. For using the GrindCare: pacemaker
3. Fulfil clinical diagnostic criteria for PD54 3. For using the BruxApp: no smartphone
4. For the DAT-SPECT: no deep brain stimulation implant present

When patients have a pacemaker, they cannot use the GrindCare GC4 (ie, a portable, single-channel electromyographic recorder to detect sleep bruxism) and will be excluded from that specific part of the study. When patients do not have a smartphone, participants cannot use the BruxApp (ie, an application on a smartphone to assess awake bruxism) and will be excluded from that specific part of the study.

DAT-SPECT, dopamine transporter single photon emission CT; PD, Parkinson’s disease.